ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,355, issued on Nov. 18, was assigned to UCB BIOPHARMA SRL (Brussels).
"Gremlin-1 crystal structure and inhibitory antibody" was invented by Neesha Dedi (Slough, Great Britain), Breda Twomey (Slough, Great Britain), Michael John Wright (Slough, Great Britain), Gareth Charles Glyndwr Davies (Slough, Great Britain) and David James Mcmillan (Slough, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to crystals of the human Gremlin-1 protein, and the human Gremlin-1 protein in complex with an inhibitory antibody. The invention also relates to the structure of human Gremlin-1 (on its own, or in complex with the antibody) ...